Skip to main content
logo
NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
2.250
-0.130 (-5.46%)
At close: May 6, 2026, 4:00 PM EDT
2.290
+0.040 (1.78%)
After-hours: May 6, 2026, 7:55 PM EDT

NovaBridge Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
260459691533473,788
Market Cap Growth
273.42%562.88%-54.82%-55.80%-90.84%12.05%
Enterprise Value
52.43250.55-101.06-155.13-145.773,128
Last Close Price
2.253.980.851.904.1847.39
PE Ratio
--8.24-3.08-0.76-0.93-9.81
PS Ratio
---242.62-223.66273.49
PB Ratio
1.121.990.340.630.825.28
P/TBV Ratio
0.931.650.340.650.825.02
P/FCF Ratio
--22.29-1.31-2.10-6.71-24.00
P/OCF Ratio
--22.30-1.32-2.11-7.00-24.74
EV/Sales Ratio
----245.4693.98225.83
EV/EBITDA Ratio
--2.661.982.172.76-9.67
EV/EBIT Ratio
--2.661.972.152.75-9.60
EV/FCF Ratio
--12.161.922.132.82-19.82
Debt / Equity Ratio
0.010.010.020.010.020.02
Debt / EBITDA Ratio
-0.03-0.03-0.08-0.05-0.21-0.05
Debt / FCF Ratio
-0.15-0.15-0.07-0.05-0.21-0.11
Net Debt / Equity Ratio
-0.90-0.90-0.84-1.27-1.16-0.91
Net Debt / EBITDA Ratio
2.212.213.314.309.252.03
Net Debt / FCF Ratio
10.0810.083.224.229.474.15
Asset Turnover
-000.000.000.01
Inventory Turnover
----021.67
Quick Ratio
7.847.8420.515.364.557.31
Current Ratio
8.098.0920.905.674.787.66
Return on Equity (ROE)
-40.89%-40.89%-22.40%-24.75%-24.79%-46.60%
Return on Assets (ROA)
-39.84%-39.84%-17.68%-15.01%-7.21%-35.26%
Return on Invested Capital (ROIC)
-291.82%-291.82%-126.83%-385.03%-102.91%-245.84%
Return on Capital Employed (ROCE)
-43.06%-43.06%-19.97%-18.20%-8.40%-39.16%
Earnings Yield
-33.95%-12.14%-32.47%-131.95%-107.85%-10.19%
FCF Yield
-7.92%-4.49%-76.10%-47.52%-14.90%-4.17%
Buyback Yield / Dilution
-17.96%-17.96%2.45%-0.86%-8.63%-11.11%
Total Shareholder Return
-17.96%-17.96%2.45%-0.86%-8.63%-11.11%
Updated Apr 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q